Tugba Ucar Akyürek

Tugba Ucar Akyürek


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 October 2024 in Pharmaceuticals
Verified
Journal Article
Open access
TATugba Ucar Akyürek
Tugba Ucar Akyürek
Ilkay Erdogan OrhanIlkay Erdogan Orhan
Ilkay Erdogan Orhan
Fatma Sezer Senol DenizFatma Sezer Senol Deniz
Fatma Sezer Senol Deniz
GEGokcen Eren
Gokcen Eren
BABUSRA ACAR
BUSRA ACAR
ASAlaattin SEN
Alaattin SEN
Background: The goal of the current study was to investigate the inhibitory activity of six phenolic compounds, i.e., rosmarinic acid, gallic acid, oleuropein, epigallocatechin gallate (EGCG), 3-hydroxytyrosol, and quercetin, against β-site amyloid precursor protein cleaving enzyme-1 (BACE1), also known as β-secretase or memapsin 2, which is implicated in the pathogenesis of Alzheimer’s disease (AD). Methods and Results: The inhibitory potential against BACE1, molecular docking simulations, as well as neurotoxicity and the effect on the AD-related gene expression of the selected phenolics were tested. BACE1 inhibitory activity was carried out using the ELISA microplate assay via fluorescence resonance energy transfer (FRET) technology. Molecular docking experiments were performed in the human BACE1 active site (PDB code: 2WJO). Neurotoxicity of the compounds was carried out in SH-SY5Y, a human neuroblastoma cell line, by the Alamar Blue method. A gene expression analysis of the compounds on fourteen genes linked to AD was conducted using the real-time polymerase chain reaction (RT-PCR) method. Rosmarinic acid, EGCG, oleuropein, and quercetin (also used as the reference) were able to inhibit BACE1 with their respective IC50 values 4.06 ± 0.68, 1.62 ± 0.12, 9.87 ± 1.01, and 3.16 ± 0.30 mM. The inhibitory compounds were observed to occupy the non-catalytic site of the BACE1. However, hydrogen bonds were found to be present between rosmarinic acid and EGCG and aspartic amino acid D228 in the catalytic site. Oleuropein and quercetin effectively suppressed the expression of PSEN, APOE, and CLU, which are recognized to be linked to the pathogenesis of AD. Conclusions: The outcomes of the work bring quercetin, EGCG, and rosmarinic acid to the forefront as promising BACE1 inhibitors.

7 October 2025 in Frontiers in Pharmacology
Verified
Journal Article
Open access
PDF file
TATugba Ucar Akyürek
Tugba Ucar Akyürek
FDF. Sezer Senol Deniz
F. Sezer Senol Deniz
ISIpek Suntar
Ipek Suntar
GEGokcen Eren
Gokcen Eren
OUOnur Kenan Ulutas
Onur Kenan Ulutas
Ilkay Erdogan OrhanIlkay Erdogan Orhan
Ilkay Erdogan Orhan
Background: Plant phenolics are increasingly being investigated for their diverse biological activities, including neuroprotective effects relevant to conditions like Alzheimer’s disease.Objective: The neurobiological potential of 37 plant phenolics was screened through a multifaceted approach encompassing in vitro enzyme inhibition and antioxidant assays, in vivo antiamnesic evaluation, and in silico molecular docking and toxicity predictions.Methods: The compounds were tested for their cholinesterase (ChE) inhibition potentials, metal-chelation activities, and copper-reducing antioxidant capacities (CUPRACs) using a microtiter assay as well as ferric-reducing antioxidant power assays. Additionally, the in silico ADME, pharmacokinetic, and toxicokinetic profiles of the compounds were predicted using computational platforms.Results: Several compounds exhibited significant inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) activities. Of these, quercetin was found to be the most active inhibitor, with IC50 values of 1.22 ± 0.79 mM against AChE and 2.51 ± 0.04 mM against BChE. Some of the other compounds, including caffeic acid (IC50: 3.51 ± 0.62 mM), apigenin (IC50: 3.52 ± 0.08 mM), and taxifolin (IC50: 7.18 ± 2.05 mM), also showed AChE inhibition. Then, oleuropein, rosmarinic acid, gallic acid, epigallocatechin gallate, and 3-hydroxytyrosol were further investigated for their antiamnesic activities using a passive avoidance test in scopolamine-induced mice; our data showed that these compounds were effective considering the latency time of the mice and that 3-hydroxytyrosol showed the highest antiamnesic effect. The dual inhibitory compounds were subjected to molecular docking experiments with ChEs, and the in silico toxicities of three compounds were assessed using the PASS and SwissADME prediction programs.Conclusion: Our data provide compelling evidence for the neuroprotective potentials of several plant phenolics. Notably, 3-hydroxytyrosol was identified for the first time as a ChE inhibitor with significant in vivo antiamnesic activity and warrants further investigation.

Verified
Journal Article
Open access
PDF file
TATugba Ucar Akyürek
Tugba Ucar Akyürek
Fatma Sezer Senol DenizFatma Sezer Senol Deniz
Fatma Sezer Senol Deniz
Ilkay Erdogan OrhanIlkay Erdogan Orhan
Ilkay Erdogan Orhan
Memet GozuboyukMemet Gozuboyuk
Memet Gozuboyuk
GEGülnur Ipek Erdemli
Gülnur Ipek Erdemli
GEGüzin Emecen
Güzin Emecen
The current study investigates the modulatory effects of gallic acid (GA), 3-hydroxytyrosol (3-HT), and quercetin (QUE) on key cholinesterase enzymes using Drosophila melanogaster (fruit fly) head homogenates as a source of central cholinesterases following in vivo larval exposure. The choice of these plant phenolics was predicated on their cholinesterase (ChE) inhibitory effect reported recently by our group. The study utilized D. melanogaster larvae subjected to varying doses of GA, 3-HT, and QUE, subsequently evaluating enzymatic activity of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE). Galanthamine HBr was used as a positive control. All three phenolic compounds exhibited elevated ΔOD/min values for BChE inhibition compared to the negative control (ethanol). GA and QUE inhibited AChE, though with lower potency than galanthamine; at 1 mM, GA and QUE achieved 79.23% and 80.98% inhibition, respectively, compared to 98.34% for galanthamine. Interestingly, the effect of 3-HT on AChE was inversely related to the dose. The results indicate that GA and QUE modulate cholinesterase activity in vivo, consistent with our prior in vitro reports. This study also provides the first in vivo evidence of 3-HT’s ChE-modulating activity in Drosophila within a whole-organism model.

30 June 2025 in Eurasian Journal of Biological and Chemical Sciences
Verified
Journal Article
Open access
PDF file
TATugba Ucar Akyürek
Tugba Ucar Akyürek
PAPelin Acar
Pelin Acar
AYArzu Bayır Yeğin
Arzu Bayır Yeğin
AEAhmet Efe
Ahmet Efe
This study explores the medicinal potential of two willow species, Salix purpurea subsp. leucodermis Yalt. and Salix caprea L., with a particular focus on their antioxidant properties. Willows are well known for their therapeutic applications, largely attributed to their phenolic and flavonoid compounds, which exhibit significant bioactive potential. In this research, we quantified the total phenolic and flavonoid contents in different plant parts—leaves, bark, and twigs—collected from distinct habitats. Considering the results of total phenolic and flavonoid content, it was observed that DPPH radical scavenging activity is notably elevated in the bark and leaves of the species, particularly in the NGBT and Kızılcahamam regions. Antioxidant capacity was also assessed using computational analyses performed with Python, with the goal of comparing the species' efficacy and exploring habitat influence on phytochemical composition. The results revealed significant variations in phenolic and flavonoid concentrations across species and habitats, underscoring the role of environmental factors in shaping metabolite accumulation. These findings contribute to the growing body of knowledge on the phytochemical applications of willows and highlight their potential as natural sources of antioxidants.

9 May 2024 in Journal of Gazi University Health Sciences Institute
Verified
Journal Article
Open access
PDF file
TATugba Ucar Akyürek
Tugba Ucar Akyürek
Ilkay Erdogan OrhanIlkay Erdogan Orhan
Ilkay Erdogan Orhan
Bacopa monnieri (L.) Wettst. (Plantaginaceae) (BM), known as “brahmi”, is a reputed medicinal plant, particularly in Ayurvedic medicine. Since BM has been traditionally used for memory dysfunction, experimental studies at the pre-clinical level support the nootropic effect of the plant relevant to Alzheimer’s disease (AD) demonstrated through various mechanisms. It has been reported that saponins (e.g. bacosides, bacopasides, and bacopasaponins) are largely responsible for the memory-enhancing and other neuropharmacological effects of BM. Bacosides, which are non-polar molecules that can easily cross the blood-brain barrier, are reported to directly lead to anti-inflammatory and antioxidant effects in the brain. BM extracts rich in bacosides are considered advantageous due to their higher nootropic efficacy. The findings suggest that only bacoside enrichment increases antiamnesic activity; other components also contribute to the extract with a synergism. Adverse side effects of BM in humans have rarely been reported. In the current review, we aimed to scrutinize in vivo data derived from the studies related to the cognitive-enhancement effect of BM with a special focus on AD.